NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

Sonographically guided core biopsy of the breast: comparison of 14-gauge automated gun and 11-gauge directional vacuum-assisted biopsy methods.

Author(s): Cho N, Moon WK, Cha JH, Kim SM, Kim SJ, Lee SH, Chung HK, Cho KS, Park IA, Noh DY

Publication: Korean J Radiol, 2005, Vol. 6, Page 102-9

PubMed ID: 15968149 PubMed Review Paper? No

Purpose of Paper

This paper compared the underestimation rate of sonographically-guided core breast biopsies obtained with a 14-gauge automated gun with those obtained with an 11-gauge vacuum-assisted device (VAD) and investigated the effects of lesion size, BI-RADS category, and lesion type on the underestimation rate.

Conclusion of Paper

The initial diagnosis of ADH or DCIS was upgraded after surgical excision in 56% of cases biopsied with a 14-gauge gun and 36% of cases biopsied with an 11-gauge VAD. However, significant differences in the upgrading between the biopsy device groups was only significant for lesions with a BI-RADS category of 4b. Malignancies were found after rebiopsy in a comparable percentage of lesions originally biopsied with a 14-gauge gun and those biopsied with an 11-gauge VAD. The underestimation rate was significantly higher for lesions less than 20 mm than those greater than 21 mm and increased with increasing BI-RADs score. 

Studies

  1. Study Purpose

    This study compared the underestimation rate of sonographically-guided core biopsies obtained with a 14-gauge automated gun and with those obtained with an 11-gauge VAD and investigated the effects of lesion size, BI-RADS category, and lesion type on the underestimation rate. A total of 979 breast lesions from 940 patients were biopsied using a 14-gauge automated gun (562 lesions from 525 patients) or an 11-gauge VAD (417 lesions from 425 patients). The VAD was preferred for calcified lesions, intraductal lesions, and solid nodules of less than 1.0 cm and the automated gun was preferred for multifocal lesions and for the lesions in the subareolar or axillary area. The average number of cores obtained with the 14-gauge gun was lower than that obtained with the 11-gauge VAD (4.5 versus 10.2). Final diagnosis was based on surgical excision or follow-up at 6, 12, or 24 months.

    Summary of Findings:

    Of the 22 cases biopsied with the 14-gauge gun and diagnosed as ADH or DCIS, twelve (56%) were upgraded (from ADH to DCIS or carcinoma or from DCIS to carcinoma) after surgical resection. In comparison, only eight of the 22 cases (36%) biopsied with an 11-gauge VAD were upgraded after surgical resection. The rate of upgrading of ADH to DCIS or invasive carcinoma after resection was 58% (7 of 12) when initial diagnosis was based on biopsy with a 14-gauge gun and 20% (1 of 5) when initial diagnosis was based on biopsy with an 11-gauge VAD. The upgrading rate of DCIS to invasive carcinoma was 50% (5/10) when initial diagnosis was based on biopsy with a 14-gauge automated gun versus 41% (7/17) when the initial diagnosis was based on biopsy with an 11-gauge VAD. However, significance between the groups was only foundfor lesions with a BI-RADS category of 4b (P=0.046). Rebiopsy was performed for 6% (33/563) of the 14-gauge gun biopsies and 4% (16 of 417) of the 11-gauge VAD. Malignancies were found after rebiopsy in a comparable percentage of lesions originally biopsied with a 14-gauge gun and those biopsied with an 11-gauge VAD (40% of 33 lesions and 31% of 16 lesions).

    The underestimation rate was significantly higher for lesions less than 20 mm than those greater than 21 mm (70% versus 34%, P=0.04) and increased with increasing BI-RADs score (88% for category 5, 50% for category 4a, 27% for category 4b, and 33% for category 3, P=0.04). Although not significantly different, the underestimation rate was 60% (6 of 10) for calcifications and 41% (14 of 34) for masses. 

    Biospecimens
    Preservative Types
    • Formalin
    Diagnoses:
    • Neoplastic - Benign
    • Neoplastic - Carcinoma
    Platform:
    AnalyteTechnology Platform
    Morphology Light microscopy
    Morphology H-and-E microscopy
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Preaquisition Prognostic factor <20 mm lesion
    >21 mm lesion
    BI-RADS 3
    BI-RADS 4a
    BI-RADS 4b
    BI-RADS 5
    Calcification
    Mass
    Biospecimen Acquisition Method of tissue acquisition Vacuum assisted biopsy
    Surgical resection
    Core needle biopsy
    Biospecimen Acquisition Needle gauge 14-gauge gun
    11-gauge VAD

You Recently Viewed  

News and Announcements

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • Most Popular SOPs in March 2024

  • New SOPs Available

  • More...